method for treatment and prevention of thrombosis using etexilate dabigatran or a salt thereof with an improved safety profile compared with the conventional therapy of warfarin

摘要

the invention relates to a method for preventing stroke in a patient with atrial fibrillation and with at least one risk factor for major bleeding events. the process consists of 110 mg b.i.d. administered dabigatran etexilate of, possibly in the form of a pharmaceutically acceptable salt thereof.